Article Details

Combining generative artificial intelligence and on-chip synthesis for de novo drug design

Retrieved on: 2021-06-11 18:03:35

Tags for this article:

Click the tags to see associated articles and topics

Combining generative artificial intelligence and on-chip synthesis for de novo drug design. View article details on hiswai:

Excerpt

With 28 molecules successfully synthesized and 12 fully validated for LXR activation in vitro, this present study pioneers the integration of generative ...

Article found on: advances.sciencemag.org

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up